1240 studies found for:    Multiple Sclerosis
Show Display Options
Rank Status Study
21 Recruiting A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif® With the RebiSmart™ Device
Conditions: Multiple Sclerosis;   Relapsing-Remitting
Interventions: Other: Technical support for the RebiSmart™ device;   Other: Patient support program (MinSupport Plus)
22 Active, not recruiting Improving Hand Use in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Behavioral: CI Therapy;   Behavioral: CAM treatments
23 Completed
Has Results
Duloxetine for Multiple Sclerosis Pain
Condition: Multiple Sclerosis
Interventions: Drug: Duloxetine Hydrochloride (HCI);   Drug: Placebo
24 Unknown  Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Serum antibodies to infectious agents using the BioPlex 2200 and complementary EIA kits
25 Completed Auditory Function in Patients With and Without Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Hearing in Multiple Sclerosis
26 Recruiting Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Prednisone;   Drug: Placebo
27 Completed Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
Conditions: Multiple Sclerosis;   Optic Neuritis;   Transverse Myelitis;   Acute Brainstem/Cerebellar Syndrome
Intervention: Drug: interferon beta 1a 30 ug IM once weekly
28 Recruiting Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition
Conditions: Relapsing-remitting Multiple Sclerosis;   Secondary-progressive Multiple Sclerosis;   Primary-progressive Multiple Sclerosis
Interventions: Drug: estriol;   Other: Placebo;   Drug: Norethindrone;   Other: Progestin Placebo
29 Completed Effects of Meditation on Multiple Sclerosis and Peripheral Neuropathy
Conditions: Multiple Sclerosis;   Peripheral Neuropathy
Intervention: Behavioral: Meditation instruction and practice
30 Recruiting Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
Conditions: Multiple Sclerosis, Primary Progressive;   Multiple Sclerosis, Secondary Progressive
Interventions: Drug: ibudilast;   Drug: Placebo
31 Completed A Observational, Prospective Study to Assess the Impact of Fatigue in the Quality of Life of Patients With Multiple Sclerosis in Argentina
Condition: Multiple Sclerosis, Relapsing-remitting
Intervention:
32 Completed Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Several diagnostic procedures
33 Completed
Has Results
A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis
Condition: Relapsing Forms of Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: Standard MS DMTs
34 Unknown  Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Interferon beta-1b and Tacrolimus
35 Completed
Has Results
A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Interferon beta-1a (Rebif)
36 Completed A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment
Condition: Multiple Sclerosis
Intervention:
37 Completed Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: intravenous injection of mesenchymal stem cells;   Biological: injection of cell free media
38 Completed
Has Results
A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: CNTO 1275
39 Terminated A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: ELND002;   Drug: Placebo
40 Not yet recruiting Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Dietary Supplement: Vitamin D3;   Dietary Supplement: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years